Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RAB23 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
mRNA | PRPS1 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
mRNA | PFN2 | CTRPv2 | pan-cancer | AAC | -0.19 | 8e-06 |
mRNA | TFE3 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
mRNA | C16orf87 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-07 |
mRNA | MAP4K1 | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-05 |
mRNA | TMEM263 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-06 |
mRNA | SKA1 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
mRNA | LOXL2 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-05 |
mRNA | WDR76 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |